ELGAR HOUSE — All Prescriptions & Medications — Page 11
Practice Code: M81002 | REDDITCH, B97 4AB
Showing results 501-550 of 600
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Mometasone/glycopyrronium/indacaterol | 17 | 570 | £803 | +12.1% ▲ |
| Travoprost | 17 | 65 | £41 | -63.9% ▼ |
| Acetic acid | 17 | 125 | £117 | +46.8% ▲ |
| 17 | 190 | £25 | -54.8% ▼ | |
| 17 | 875 | £1.3K | +104.9% ▲ | |
| 17 | 770 | £738 | -48.2% ▼ | |
| 17 | 350 | £1.1K | -8.9% ▼ | |
| Lidocaine hydrochloride | 16 | 849 | £89 | +248.7% ▲ |
| Cyanocobalamin | 16 | 1,097 | £86 | -95.5% ▼ |
| Sodium zirconium cyclosilicate | 16 | 480 | £4.4K | +82.1% ▲ |
| Apraclonidine | 16 | 1,056 | £4.8K | +27.0% ▲ |
| Zinc oxide | 16 | 2,290 | £84 | -20.4% ▼ |
| Ivermectin | 16 | 870 | £504 | -24.7% ▼ |
| 16 | 51 | £715 | +22.4% ▲ | |
| 16 | 960 | £297 | -49.6% ▼ | |
| Alverine citrate/simeticone | 15 | 1,350 | £157 | +43.5% ▲ |
| Nizatidine | 15 | 864 | £628 | -56.4% ▼ |
| Olmesartan medoxomil | 15 | 756 | £28 | -78.2% ▼ |
| Nitrazepam | 15 | 528 | £28 | -71.1% ▼ |
| Calcium acetate | 15 | 2,688 | £191 | -18.9% ▼ |
| Tafluprost | 15 | 630 | £256 | -19.1% ▼ |
| Azelaic acid | 15 | 540 | £85 | -37.3% ▼ |
| Co-cyprindiol (Cyprote acetate/ethinylestradiol) | 15 | 903 | £111 | +72.9% ▲ |
| 15 | 654 | £130 | -69.7% ▼ | |
| 15 | 95 | £266 | +60.4% ▲ | |
| Budesonide | 14 | 1,276 | £1.8K | -10.6% ▼ |
| Telmisartan | 14 | 574 | £205 | -75.9% ▼ |
| Risperidone | 14 | 28 | £4.0K | -8.3% ▼ |
| Ofloxacin | 14 | 322 | £585 | +70.4% ▲ |
| Testosterone undecanoate | 14 | 14 | £1.2K | -44.9% ▼ |
| Levonorgestrel | 14 | 1,617 | £41 | +72.2% ▲ |
| Tacrolimus | 14 | 800 | £1.2K | -47.7% ▼ |
| Cyproterone acetate | 14 | 840 | £1.3K | +27.5% ▲ |
| RtS 1.4-1.5kcal/ml energy & higher protein liquid (0913141) | 14 | 1,080 | £2.5K | +44.4% ▲ |
| Powder thickener - starch based (0913161) | 14 | 1,890 | £53 | -2.5% ▼ |
| Tube feed 1.5 kcal/ml with fibre (0914011) | 14 | 233.0K | £4.3K | +21.1% ▲ |
| Tube feed 1 kcal/ml peptide based (0914032) | 14 | 389.5K | £9.2K | +56.9% ▲ |
| Nabumetone | 14 | 644 | £195 | +0.7% vs avg |
| 14 | 140 | £1.1K | -20.3% ▼ | |
| 14 | 28 | £127 | -65.6% ▼ | |
| 14 | 33 | £3.8K | -60.8% ▼ | |
| 14 | 685 | £2.2K | -31.8% ▼ | |
| 14 | 1,288 | £87 | -49.1% ▼ | |
| Flupentixol hydrochloride | 13 | 812 | £63 | -60.3% ▼ |
| Rimegepant | 13 | 104 | £1.3K | +32.5% ▲ |
| Zonisamide | 13 | 1,120 | £478 | -70.2% ▼ |
| Opicapone | 13 | 280 | £552 | -32.1% ▼ |
| Rotigotine | 13 | 392 | £1.9K | -51.8% ▼ |
| Tetrabenazine | 13 | 966 | £1.0K | -18.0% ▼ |
| Colistimethate sodium | 13 | 750 | £1.4K | +15.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.